XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 93 filers reported holding XENON PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $9,837,000 | +18.7% | 272,500 | 0.0% | 4.24% | -8.3% |
| Q2 2022 | $8,289,000 | +20.5% | 272,500 | +21.1% | 4.62% | +43.7% |
| Q1 2022 | $6,878,000 | -2.1% | 225,000 | 0.0% | 3.21% | +8.8% |
| Q4 2021 | $7,029,000 | +10.2% | 225,000 | -46.1% | 2.96% | +31.3% |
| Q3 2021 | $6,378,000 | -17.9% | 417,409 | 0.0% | 2.25% | -27.6% |
| Q2 2021 | $7,772,000 | +5.3% | 417,409 | +1.2% | 3.11% | +16.7% |
| Q1 2021 | $7,384,000 | +500.3% | 412,500 | +415.6% | 2.66% | +694.6% |
| Q4 2020 | $1,230,000 | -63.0% | 80,000 | -73.3% | 0.34% | -62.9% |
| Q3 2020 | $3,321,000 | -48.8% | 300,000 | -42.0% | 0.90% | -51.9% |
| Q2 2020 | $6,489,000 | -9.0% | 517,500 | -17.7% | 1.88% | -45.7% |
| Q1 2020 | $7,127,000 | -40.7% | 628,500 | -31.5% | 3.45% | +15.9% |
| Q4 2019 | $12,028,000 | +90.0% | 917,500 | +30.6% | 2.98% | -34.8% |
| Q3 2019 | $6,330,000 | -8.5% | 702,500 | +0.1% | 4.57% | +85.7% |
| Q2 2019 | $6,917,000 | +23.2% | 701,500 | +27.0% | 2.46% | -7.8% |
| Q1 2019 | $5,613,000 | +65.5% | 552,500 | +2.8% | 2.67% | +3.2% |
| Q4 2018 | $3,392,000 | -46.7% | 537,500 | +11.4% | 2.59% | +13.9% |
| Q3 2018 | $6,369,000 | +53.8% | 482,500 | +7.2% | 2.27% | +208.3% |
| Q2 2018 | $4,140,000 | – | 450,000 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |